Jon Isaacsohn
No más puestos en curso
Historial de carrera de Jon Isaacsohn
Antiguos cargos conocidos de Jon Isaacsohn.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CINCOR PHARMA, INC. | Director/Miembro de la Junta | 06/07/2021 | 01/11/2021 |
| Director Ejecutivo | - | 06/07/2021 | |
| Director Técnico/Científico/I+D | 06/07/2021 | 01/11/2021 | |
| Fundador | - | 01/11/2021 |
Estadísticas
Internacional
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jon Isaacsohn
- Experiencia
